check_circleStudy Completed
Erectile Dysfunction
Bayer Identifier:
11575
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Assessment of duration of erection with vardenafil 10 mg
Trial purpose
This study assessed the effect of 10mg vardenafil, taken on demand in an 'at home' setting, as compared to placebo (dummy medication with no pharmacological activity), on the duration of erection from the moment when the patient perceived his erection to be hard enough for penetration until withdrawal from the partner's vagina leading to successful completion which may or may not have included ejaculation. The patient used the stopwatch for the above assessments. The efficacy of oral ED treatments is measured by questionnaires and patient diaries.
Key Participants Requirements
Sex
MaleAge
18 - 64 YearsTrial summary
Enrollment Goal
201Trial Dates
September 2004 - April 2005Phase
Phase 4Could I Receive a placebo
YesProducts
Levitra (Vardenafil, BAY38-9456)Accepts Healthy Volunteer
NoPrimary Outcome
- Effect of vardenafil on the duration of erectiondate_rangeTime Frame:4 weeksenhanced_encryptionnoSafety Issue:
Secondary Outcome
- Perception of erection to be hard enough for penetrationdate_rangeTime Frame:4 weeksenhanced_encryptionnoSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
RandomizedBlinding
Double BlindAssignment
Crossover AssignmentTrial Arms
2